IP Library Granted Patent US 10,801,052
Granted Patent B2
US 10,801,052 · App. 14/349,126 · Granted Oct 13, 2020

Cofactor regeneration system

Inventors: Kylie Vincent (Oxford, GB); Lars Lauterbach (Berlin, DE); Oliver Lenz (Berlin, DE)
Assignees: OXFORD UNIVERSITY INNOVATION LIMITED; HUMBOLDT-UNIVERSITAT ZU BERLIN
C12P19/36C12N9/0036C12N9/0051C12Y106/99001C12Y108/01004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,801,052
App. No.
14/349,126
Granted
Oct 13, 2020
Kind
B2
Abstract

The present invention relates to cofactor regeneration systems, components and uses thereof and methods for generating and regenerating cofactors. The cofactor regeneration system comprises a first electron transfer component selected from a polypeptide comprising a NADH:acceptor oxido-reductase or NADPH:acceptor oxido-reductase, a second electron transfer component selected from a hydrogenase moiety and/or non-biological nanoparticles and an electronically conducting surface. The first and second electron transfer components are immobilised on the electrically conducting surface, and the first and second electron transfer components do not occur together in nature as an enzyme complex.

Claims (15)

1. A system for the regeneration of the cofactors nicotinamide adenine dinucleotide (NAD+), the reduced form of NAD+ (NADH), nicotinamide adenine dinucleotide phosphate (NADP+), and the reduced form of NADP+ (NADPH), the system comprising:

i) a first electron transfer component comprising a diaphorase, wherein said diaphorase comprises a first polypeptide comprising a sequence having at least 94% identity to SEQ ID NO: 1 and a second polypeptide comprising a sequence having at least 80% identity to SEQ ID NO: 2, wherein the combination of the first and second sequences provides oxidoreductase activity;

ii) a second electron transfer component comprising a hydrogenase, wherein said hydrogenase comprises a first polypeptide comprising a sequence having at least 95% identity to SEQ ID NO: 33 and a second polypeptide comprising a sequence having at least 90% identity to SEQ ID NO: 34, wherein the combination of the first and second sequences provides hydrogenase activity; and,

iii) an electronically conducting surface wherein said electronically conducting surface is a carbon particle;

wherein the first and second electron transfer components are immobilised on the carbon particle, wherein the first and second electron transfer components do not occur together in nature as an enzyme complex, and wherein, when the cofactor regeneration system is in use, electrons flow:

from the first electron transfer component via the carbon particle to the second electron transfer component; or

from the second electron transfer component via the carbon particle to the first electron transfer component.

2. The cofactor regeneration system according to claim 1 , wherein the diaphorase has increased oxidoreductase activity compared to Ralstonia eutropha diaphorase consisting of SEQ ID NO: 1 and SEQ ID NO: 2.

3. The cofactor regeneration system according to claim 2 , wherein the catalytic activity of said diaphorase is increased by a factor of at least 50.

4. The cofactor regeneration system according to claim 1 , wherein the hydrogenase does not comprise a flavin mononucleotide (FMN) prosthetic group, does not comprise a flavin adenine dinucleotide (FAD) prosthetic group, or does not comprise a FMN prosthetic group and does not comprise a FAD prosthetic group.

5. The cofactor regeneration system according to claim 1 , further comprising NAD+.

6. A kit comprising the cofactor regeneration system according to claim 1 , and a cofactor selected from NAD, NADH, NADP and/or NADPH.

7. The cofactor regeneration system according to claim 1 , further comprising NADH.

8. The cofactor regeneration system according to claim 1 , further comprising NADP+.

9. The cofactor regeneration system according to claim 1 , further comprising NADPH.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2023
From: HUMBOLDT-UNIVERSITAT ZU BERLIN
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 062740/0197 →
CHANGE OF NAME Recorded Aug 2, 2016
From: ISIS INNOVATION LIMITED
To: OXFORD UNIVERSITY INNOVATION LIMITED
Reel/Frame 039550/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2014
From: VINCENT, KYLIE; LAUTERBACH, LARS; LENZ, OLIVER
To: ISIS INNOVATION LIMITED; HUMBOLDT-UNIVERSITAT ZU BERLIN
Reel/Frame 033883/0929 →
Priority Claims (1)
GB 1116971.1 · Oct 3, 2011 · national
Continuity (1)
Related Publication 20150044723A1 · Feb 12, 2015
Cited By (1)
US 12,655,454